Cite

HARVARD Citation

    de Marinis, F. et al. (2015). Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial. Future oncology. pp. 421-429. [Online]. 
  
Back to record